How has been the historical performance of the Ajooni Biotech?
Ajooni Biotech has shown significant growth in net sales and profitability, with net sales increasing from Rs 39.72 crore in March 2019 to Rs 114.69 crore in March 2025, despite facing cash flow challenges. Profit after tax rose to Rs 3.37 crore in March 2025 from Rs 0.41 crore in March 2019.
Answer:The historical performance of Ajooni Biotech shows a significant upward trend in net sales and profitability over the years, culminating in the fiscal year ending March 2025.Breakdown:
Ajooni Biotech's net sales have increased from Rs 39.72 crore in March 2019 to Rs 114.69 crore in March 2025, reflecting a strong growth trajectory. Total operating income has similarly risen, reaching Rs 114.69 crore in March 2025 from Rs 40.06 crore in March 2019. The company's total expenditure, excluding depreciation, has also grown, amounting to Rs 111.01 crore in March 2025, up from Rs 39.17 crore in March 2019. Operating profit, excluding other income, has shown fluctuations but reached Rs 3.68 crore in March 2025, compared to Rs 0.89 crore in March 2019. Profit before tax has increased to Rs 4.33 crore in March 2025 from Rs 0.47 crore in March 2019, while profit after tax has risen to Rs 3.37 crore from Rs 0.41 crore in the same period. The company's earnings per share (EPS) peaked at Rs 0.98 in March 2025, although it was higher in March 2024 at Rs 1.09. The total assets of Ajooni Biotech decreased to Rs 47.21 crore in March 2024 from Rs 58.46 crore in March 2023, while total liabilities also fell to Rs 47.21 crore in March 2024 from Rs 58.46 crore in March 2023. Cash flow from operating activities has been negative in recent years, indicating challenges in cash generation, with a cash flow of Rs -3.00 crore in March 2024. Overall, Ajooni Biotech has demonstrated significant growth in sales and profitability, despite facing cash flow challenges.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
